{"count": 161, "results": [{"_id": "33599105", "pmid": 33599105, "pmcid": "PMC8251758", "title": "Combination of bis (alpha-furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through down-regulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice Combination of bis (alpha -furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through downregulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice", "journal": "Basic Clin Pharmacol Toxicol", "authors": ["Liu Q", "Li L", "Gao L", "Li C", "Huan Y", "Lei L", "Cao H", "Li L", "Gao A", "Liu S", "Shen Z"], "date": "2021-06-01T00:00:00Z", "doi": "10.1111/bcpt.13573", "meta_date_publication": "2021 Jun", "meta_volume": "128", "meta_issue": "6", "meta_pages": "747-757", "score": 50278.598, "text_hl": "The combination of BFOV and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ improves @<m>DISEASE_Fatty_Liver</m> @DISEASE_MESH:D005234 @@@hepatic steatosis@@@ in HFC57 mice", "citations": {"NLM": "Liu Q, Li L, Gao L, Li C, Huan Y, Lei L, Cao H, Li L, Gao A, Liu S, Shen Z. Combination of bis (alpha-furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through down-regulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice Combination of bis (alpha -furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through downregulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice Basic Clin Pharmacol Toxicol. 2021 Jun;128(6):747-757. PMID: 33599105", "BibTeX": "@article{33599105, title={Combination of bis (alpha-furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through down-regulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice Combination of bis (alpha -furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through downregulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice}, author={Liu Q and Li L and Gao L and Li C and Huan Y and Lei L and Cao H and Li L and Gao A and Liu S and Shen Z}, journal={Basic Clin Pharmacol Toxicol}, volume={128}, number={6}, pages={747-757}}"}}, {"_id": "35056941", "pmid": 35056941, "pmcid": "PMC8780287", "title": "The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model", "journal": "Pharmaceutics", "authors": ["Hüttl M", "Markova I", "Miklankova D", "Zapletalova I", "Poruba M", "Racova Z", "Vecera R", "Malinska H"], "date": "2021-12-27T00:00:00Z", "doi": "10.3390/pharmaceutics14010045", "meta_date_publication": "2021 Dec 27", "meta_volume": "14", "meta_issue": "1", "meta_pages": "", "score": 50272.89, "text_hl": "The Beneficial Additive Effect of @CHEMICAL_Silymarin @CHEMICAL_MESH:D012838 @@@Silymarin@@@ in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Therapy of @<m>DISEASE_Fatty_Liver</m> @DISEASE_MESH:D005234 @@@Liver Steatosis@@@ in a Pre-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetic@@@ Model", "citations": {"NLM": "Hüttl M, Markova I, Miklankova D, Zapletalova I, Poruba M, Racova Z, Vecera R, Malinska H. The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model Pharmaceutics. 2021 Dec 27;14(1):. PMID: 35056941", "BibTeX": "@article{35056941, title={The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model}, author={Hüttl M and Markova I and Miklankova D and Zapletalova I and Poruba M and Racova Z and Vecera R and Malinska H}, journal={Pharmaceutics}, volume={14}, number={1}}"}}, {"_id": "36430717", "pmid": 36430717, "pmcid": "PMC9694630", "title": "Maternal Metformin Treatment Reprograms Maternal High-Fat Diet-Induced Hepatic Steatosis in Offspring Associated with Placental Glucose Transporter Modifications", "journal": "Int J Mol Sci", "authors": ["Huang CF", "Tiao MM", "Lin IC", "Huang LT", "Sheen JM", "Tain YL", "Hsu CN", "Tsai CC", "Lin YJ", "Yu HR"], "date": "2022-11-17T00:00:00Z", "doi": "10.3390/ijms232214239", "meta_date_publication": "2022 Nov 17", "meta_volume": "23", "meta_issue": "22", "meta_pages": "", "score": 50270.535, "text_hl": "Maternal @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Treatment Reprograms Maternal High-Fat Diet-Induced @<m>DISEASE_Fatty_Liver</m> @DISEASE_MESH:D005234 @@@Hepatic Steatosis@@@ in Offspring Associated with Placental Glucose Transporter Modifications", "citations": {"NLM": "Huang CF, Tiao MM, Lin IC, Huang LT, Sheen JM, Tain YL, Hsu CN, Tsai CC, Lin YJ, Yu HR. Maternal Metformin Treatment Reprograms Maternal High-Fat Diet-Induced Hepatic Steatosis in Offspring Associated with Placental Glucose Transporter Modifications Int J Mol Sci. 2022 Nov 17;23(22):. PMID: 36430717", "BibTeX": "@article{36430717, title={Maternal Metformin Treatment Reprograms Maternal High-Fat Diet-Induced Hepatic Steatosis in Offspring Associated with Placental Glucose Transporter Modifications}, author={Huang CF and Tiao MM and Lin IC and Huang LT and Sheen JM and Tain YL and Hsu CN and Tsai CC and Lin YJ and Yu HR}, journal={Int J Mol Sci}, volume={23}, number={22}}"}}, {"_id": "35326230", "pmid": 35326230, "pmcid": "PMC8945168", "title": "Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice", "journal": "Antioxidants (Basel)", "authors": ["Choi JY", "Jang TW", "Song PH", "Choi SH", "Ku SK", "Song CH"], "date": "2022-03-18T00:00:00Z", "doi": "10.3390/antiox11030580", "meta_date_publication": "2022 Mar 18", "meta_volume": "11", "meta_issue": "3", "meta_pages": "", "score": 50270.07, "text_hl": "Histopathological analyses revealed that the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ combination ameliorated the @DISEASE_Hypertrophy @DISEASE_MESH:D006984 @@@hepatic hypertrophy@@@/@<m>DISEASE_Fatty_Liver</m> @DISEASE_MESH:D005234 @@@steatosis@@@, pancreatic endocrine/exocrine alteration, @CHEMICAL_Fats @CHEMICAL_MESH:D005223 @@@fat@@@ tissue @DISEASE_Hypertrophy @DISEASE_MESH:D006984 @@@hypertrophy@@@, and @<m>DISEASE_Fatty_Liver</m> @DISEASE_MESH:D005234 @@@renal steatosis@@@, more than either monotherapy. ", "citations": {"NLM": "Choi JY, Jang TW, Song PH, Choi SH, Ku SK, Song CH. Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice Antioxidants (Basel). 2022 Mar 18;11(3):. PMID: 35326230", "BibTeX": "@article{35326230, title={Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice}, author={Choi JY and Jang TW and Song PH and Choi SH and Ku SK and Song CH}, journal={Antioxidants (Basel)}, volume={11}, number={3}}"}}, {"_id": "33859820", "pmid": 33859820, "pmcid": "PMC8042663", "title": "Effects of obesity and 10 weeks metformin treatment on liver steatosis", "journal": "Biomed Rep", "authors": ["Hakkak R", "Rose S", "Spray B", "Kozaczek M", "Korourian S"], "date": "2021-06-01T00:00:00Z", "doi": "10.3892/br.2021.1425", "meta_date_publication": "2021 Jun", "meta_volume": "14", "meta_issue": "6", "meta_pages": "49", "score": 50266.824, "text_hl": "Effects of @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ and 10 weeks @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment on @<m>DISEASE_Fatty_Liver</m> @DISEASE_MESH:D005234 @@@liver steatosis@@@", "citations": {"NLM": "Hakkak R, Rose S, Spray B, Kozaczek M, Korourian S. Effects of obesity and 10 weeks metformin treatment on liver steatosis Biomed Rep. 2021 Jun;14(6):49. PMID: 33859820", "BibTeX": "@article{33859820, title={Effects of obesity and 10 weeks metformin treatment on liver steatosis}, author={Hakkak R and Rose S and Spray B and Kozaczek M and Korourian S}, journal={Biomed Rep}, volume={14}, number={6}, pages={49}}"}}, {"_id": "35080048", "pmid": 35080048, "pmcid": "PMC9303255", "title": "Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease", "journal": "J Gastroenterol Hepatol", "authors": ["Chan WK", "Tan SS", "Chan SP", "Lee YY", "Tee HP", "Mahadeva S", "Goh KL", "Ramli AS", "Mustapha F", "Kosai NR", "Raja Ali RA"], "date": "2022-05-01T00:00:00Z", "doi": "10.1111/jgh.15787", "meta_date_publication": "2022 May", "meta_volume": "37", "meta_issue": "5", "meta_pages": "795-811", "score": 50266.77, "text_hl": "Lifestyle intervention is the cornerstone in the management of @<m>DISEASE_Fatty_Liver</m> @DISEASE_MESH:D005234 @@@MAFLD@@@. The panel provided a consensus on the use of statin, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, sodium-glucose cotransporter-2 inhibitor, @GENE_GCG @GENE_2641 @@@glucagon-like peptide-1@@@ agonist, @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@, @CHEMICAL_Vitamin_E @CHEMICAL_MESH:D014810 @@@vitamin E@@@, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, as well as recommendations on bariatric surgery, screening for @DISEASE_Varicose_Veins @DISEASE_MESH:D014648 @@@gastroesophageal varices@@@ and @DISEASE_Carcinoma_Hepatocellular @DISEASE_MESH:D006528 @@@hepatocellular carcinoma@@@, and liver transplantation in @<m>DISEASE_Fatty_Liver</m> @DISEASE_MESH:D005234 @@@MAFLD@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Chan WK, Tan SS, Chan SP, Lee YY, Tee HP, Mahadeva S, Goh KL, Ramli AS, Mustapha F, Kosai NR, Raja Ali RA. Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease J Gastroenterol Hepatol. 2022 May;37(5):795-811. PMID: 35080048", "BibTeX": "@article{35080048, title={Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease}, author={Chan WK and Tan SS and Chan SP and Lee YY and Tee HP and Mahadeva S and Goh KL and Ramli AS and Mustapha F and Kosai NR and Raja Ali RA}, journal={J Gastroenterol Hepatol}, volume={37}, number={5}, pages={795-811}}"}}, {"_id": "36830859", "pmid": 36830859, "pmcid": "PMC9952909", "title": "Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study", "journal": "Biomedicines", "authors": ["Caturano A", "Galiero R", "Loffredo G", "Vetrano E", "Medicamento G", "Acierno C", "Rinaldi L", "Marrone A", "Salvatore T", "Monda M", "Sardu C", "Marfella R", "Sasso FC"], "date": "2023-01-23T00:00:00Z", "doi": "10.3390/biomedicines11020322", "meta_date_publication": "2023 Jan 23", "meta_volume": "11", "meta_issue": "2", "meta_pages": "", "score": 50265.582, "text_hl": "In @SPECIES_9606 @@@patients@@@ affected by T2DM, the combination of @CHEMICAL_empagliflozin @CHEMICAL_MESH:C570240 @@@empagliflozin@@@ + @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ vs. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ monotherapy ameliorated @<m>DISEASE_Fatty_Liver</m> @DISEASE_MESH:D005234 @@@liver steatosis@@@, ALT levels, body weight, and glycated hemoglobin after a 6-month follow-up.", "citations": {"NLM": "Caturano A, Galiero R, Loffredo G, Vetrano E, Medicamento G, Acierno C, Rinaldi L, Marrone A, Salvatore T, Monda M, Sardu C, Marfella R, Sasso FC. Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study Biomedicines. 2023 Jan 23;11(2):. PMID: 36830859", "BibTeX": "@article{36830859, title={Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study}, author={Caturano A and Galiero R and Loffredo G and Vetrano E and Medicamento G and Acierno C and Rinaldi L and Marrone A and Salvatore T and Monda M and Sardu C and Marfella R and Sasso FC}, journal={Biomedicines}, volume={11}, number={2}}"}}, {"_id": "33426334", "pmid": 33426334, "pmcid": "PMC7779780", "title": "PSTi8 with metformin ameliorates perimenopause induced steatohepatitis associated ER stress by regulating SIRT-1/SREBP-1c axis", "journal": "Heliyon", "authors": ["Singh P", "Reza MI", "Syed AA", "Garg R", "Husain A", "Katekar R", "Goand UK", "Riyazuddin M", "Gupta AP", "Gayen JR"], "date": "2020-12-29T00:00:00Z", "doi": "10.1016/j.heliyon.2020.e05826", "meta_date_publication": "2020 Dec", "meta_volume": "6", "meta_issue": "12", "meta_pages": "e05826", "score": 50264.953, "text_hl": "PSTi8 with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ ameliorates perimenopause induced @<m>DISEASE_Fatty_Liver</m> @DISEASE_MESH:D005234 @@@steatohepatitis@@@ associated ER stress by regulating @GENE_SIRT1 @GENE_23411 @@@SIRT-1@@@/@GENE_SREBF1 @GENE_6720 @@@SREBP-1c@@@ axis", "citations": {"NLM": "Singh P, Reza MI, Syed AA, Garg R, Husain A, Katekar R, Goand UK, Riyazuddin M, Gupta AP, Gayen JR. PSTi8 with metformin ameliorates perimenopause induced steatohepatitis associated ER stress by regulating SIRT-1/SREBP-1c axis Heliyon. 2020 Dec;6(12):e05826. PMID: 33426334", "BibTeX": "@article{33426334, title={PSTi8 with metformin ameliorates perimenopause induced steatohepatitis associated ER stress by regulating SIRT-1/SREBP-1c axis}, author={Singh P and Reza MI and Syed AA and Garg R and Husain A and Katekar R and Goand UK and Riyazuddin M and Gupta AP and Gayen JR}, journal={Heliyon}, volume={6}, number={12}, pages={e05826}}"}}, {"_id": "38273354", "pmid": 38273354, "pmcid": "PMC10809441", "title": "Yam Gruel alone and in combination with metformin regulates hepatic lipid metabolism disorders in a diabetic rat model by activating the AMPK/ACC/CPT-1 pathway", "journal": "Lipids Health Dis", "authors": ["Dai Y", "Qiu C", "Zhang D", "Li M", "Liu W"], "date": "2024-01-25T00:00:00Z", "doi": "10.1186/s12944-024-02014-2", "meta_date_publication": "2024 Jan 25", "meta_volume": "23", "meta_issue": "1", "meta_pages": "28", "score": 50263.74, "text_hl": "The concentrations of @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ indices (@CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@TG@@@, TC, @CHEMICAL_Fatty_Acids_Nonesterified @CHEMICAL_MESH:D005230 @@@NEFA@@@, and LDL-C), the levels of liver function indices (ALT and AST) and the degree of @<m>DISEASE_Fatty_Liver</m> @DISEASE_MESH:D005234 @@@hepatic steatosis@@@ was improved in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@ that were treated with Yam Gruel with or without @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Dai Y, Qiu C, Zhang D, Li M, Liu W. Yam Gruel alone and in combination with metformin regulates hepatic lipid metabolism disorders in a diabetic rat model by activating the AMPK/ACC/CPT-1 pathway Lipids Health Dis. 2024 Jan 25;23(1):28. PMID: 38273354", "BibTeX": "@article{38273354, title={Yam Gruel alone and in combination with metformin regulates hepatic lipid metabolism disorders in a diabetic rat model by activating the AMPK/ACC/CPT-1 pathway}, author={Dai Y and Qiu C and Zhang D and Li M and Liu W}, journal={Lipids Health Dis}, volume={23}, number={1}, pages={28}}"}}, {"_id": "36120597", "pmid": 36120597, "pmcid": "PMC9481363", "title": "Exercise and Metformin Intervention Prevents Lipotoxicity-Induced Hepatocyte Apoptosis by Alleviating Oxidative and ER Stress and Activating the AMPK/Nrf2/HO-1 Signaling Pathway in db/db Mice", "journal": "Oxid Med Cell Longev", "authors": ["Zhang Y", "Liu Y", "Liu X", "Yuan X", "Xiang M", "Liu J", "Zhang L", "Zhu S", "Lu J", "Tang Q", "Cheng S"], "date": "2022-09-09T00:00:00Z", "doi": "10.1155/2022/2297268", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "2297268", "score": 50263.703, "text_hl": " Compared to @GENE_SLTM @GENE_79811 @@@MET@@@ or exercise intervention alone, the combined exercise and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ exhibited significant effect on ameliorating @<m>DISEASE_Fatty_Liver</m> @DISEASE_MESH:D005234 @@@hepatic steatosis@@@, inhibiting oxidative and ER stress-induced hepatocyte apoptosis via improving the capacity of the antioxidant defense system and suppression of the @GENE_EIF2AK3 @GENE_9451 @@@PERK@@@-@GENE_EIF2A @GENE_83939 @@@eIF2alpha@@@-@GENE_ATF4 @GENE_468 @@@ATF4@@@ pathway. ", "citations": {"NLM": "Zhang Y, Liu Y, Liu X, Yuan X, Xiang M, Liu J, Zhang L, Zhu S, Lu J, Tang Q, Cheng S. Exercise and Metformin Intervention Prevents Lipotoxicity-Induced Hepatocyte Apoptosis by Alleviating Oxidative and ER Stress and Activating the AMPK/Nrf2/HO-1 Signaling Pathway in db/db Mice Oxid Med Cell Longev. 2022;2022():2297268. PMID: 36120597", "BibTeX": "@article{36120597, title={Exercise and Metformin Intervention Prevents Lipotoxicity-Induced Hepatocyte Apoptosis by Alleviating Oxidative and ER Stress and Activating the AMPK/Nrf2/HO-1 Signaling Pathway in db/db Mice}, author={Zhang Y and Liu Y and Liu X and Yuan X and Xiang M and Liu J and Zhang L and Zhu S and Lu J and Tang Q and Cheng S}, journal={Oxid Med Cell Longev}, volume={2022}, pages={2297268}}"}}]}